In both murine and human systems, IL-3 indirectly inhibited osteoblast formation in a dose-dependent manner, and IL-3 levels in the BM plasma from MM patients were increased in approximately 70% of patients compared to normal controls or MGUS patients [84]. This evidence concerns the gene IL3 and Miyoshi myopathy.